ARCTURUS THERAPEUTICS HOLDINGS INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $5.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-03
- ARCTURUS THERAPEUTICS HOLDINGS INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $5.50M, a 81.16% decline from fiscal 2024.
- ARCTURUS THERAPEUTICS HOLDINGS INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $29.20M, a 186.27% increase from fiscal 2023.
- ARCTURUS THERAPEUTICS HOLDINGS INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $10.20M, a 920.00% increase from fiscal 2022.
- ARCTURUS THERAPEUTICS HOLDINGS INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $1.00M, a 98.16% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $5.50M 10-K · filed 2026-03-03 | |
| 2024-12-31 | $29.20M 10-K · filed 2026-03-03 | |
| 2023-12-31 | $10.20M 10-K · filed 2025-03-06 | |
| 2022-12-31 | $1.00M 10-K · filed 2024-03-14 | -$1.00M 10-K · filed 2023-03-29 |
| 2021-12-31 | $54.30M 10-K · filed 2023-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |